Vapor Group Inc. (VPOR): I would Hyper-vapor-late, I mean Hyperve...

Home > Boards > US OTC > Cannabis > Vapor Group Inc. (VPOR)

Followed By	71
Posts	2592
Boards Moderated	0
Alias Born	02/09/2012

The Hook

Tuesday, June 03, 2014 9:33:45 PM

Re: Welcome2Pinkyland post# 29275

I would Hyper-vapor-late, I mean Hyperventilate if we started Franchising (VPOR) Stores, we will have arrived in fine fashion if that should happen...:) :) :) WeeeeeeeeeeeeeeeeeeeeeeeeD !!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation

Bank of America Raises U.S. Minimum Wage to $22 an Hour
DiDi Announces Results of Extraordinary General Meeting
Ocwen Board of Directors Authorizes $50 Million Share Repurchase Program
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
VMware Shares Jump Premarket After Reports of Takeover Talks
So-Young Reports Unaudited First Quarter 2022 Financial Results
Kala Announces Entry into Definitive Agreement to Sell EYSUVIS® and INVELTYS® to Alcon Inc.
AMD Showcases Industry-Leading Gaming, Commercial, and Mainstream PC Technologies at COMPUTEX 2022
Farmmi Receives Nasdaq Delisting Determination; Plans to Appeal
Ford Pro Leading Companies into Electrified Future with Electric Vehicles, Charging Solutions, In-Vehicle Software
Real-World Data Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide than Previously Reported
NYMOX Receives RTF letter from FDA
Borqs Technologies Forms a Strategic Partnership with SkyCentrics to develop the Next Generation of CTA-2045 Smart Control Products for use by Solar Companies for “Electrification of Everything”
Catalyst Biosciences Sells Complement Portfolio for $60 Million
J.P. Morgan Asset Management Hires New Global Data Science Head, Arezu Moghadam
Cornerstone Strategic Value Fund, Inc. Announces the Resumption of its Rights Offering and Change in June 2022 Distribution Record Date
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the Tumor Myeloid-Directed Therapies Summit Annual Meeting
View Announces Earnings Date for Tuesday, May 31st, 2022
SEC Fines BNY Mellon Unit Over ESG Claims
Catalyst Biosciences Shares Soar After Complement Portfolio Sale

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

Detailed Quote